Enwei Pharmaceutical Co., Ltd. (SHE:301331)

Enwei Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 22, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,194	2,307	2,911	2,789	-	-
Market Cap Growth	48.05%	-20.75%	4.40%	-	-	-
Enterprise Value	2,840	2,014	2,403	2,225	-	-
Last Close Price	31.60	22.94	27.32	25.21	-	-
PE Ratio	54.60	61.53	33.73	41.13	-	-
PS Ratio	3.66	2.84	3.71	4.03	-	-
PB Ratio	2.95	2.18	2.64	2.42	-	-
P/TBV Ratio	3.73	2.80	3.41	2.76	-	-
P/FCF Ratio	352.76	80.43	-	71.88	-	-
P/OCF Ratio	50.04	29.24	34.66	44.72	-	-
EV/Sales Ratio	3.25	2.48	3.06	3.22	-	-
EV/EBITDA Ratio	25.35	23.18	20.87	22.42	-	-
EV/EBIT Ratio	43.27	47.96	29.89	32.57	-	-
EV/FCF Ratio	313.64	70.19	-	57.35	-	-
Debt / Equity Ratio	0.17	0.19	0.00	-	-	-
Debt / EBITDA Ratio	1.61	2.25	0.01	-	-	-
Debt / FCF Ratio	19.98	6.90	-	-	-	-
Asset Turnover	0.59	0.57	0.57	0.61	0.79	0.79
Inventory Turnover	3.69	3.63	3.63	3.23	3.17	3.65
Quick Ratio	3.53	3.42	3.16	3.64	1.38	1.29
Current Ratio	4.11	3.99	3.75	4.21	2.08	1.75
Return on Equity (ROE)	5.52%	3.47%	7.65%	7.55%	16.56%	19.64%
Return on Assets (ROA)	2.75%	1.85%	3.66%	3.75%	7.25%	8.12%
Return on Capital (ROIC)	3.28%	2.22%	4.45%	4.76%	10.14%	11.99%
Return on Capital Employed (ROCE)	5.10%	3.30%	7.10%	5.80%	14.90%	16.90%
Earnings Yield	1.81%	1.63%	2.96%	2.43%	-	-
FCF Yield	0.28%	1.24%	-1.72%	1.39%	-	-
Dividend Yield	0.57%	0.78%	1.98%	6.35%	-	-
Payout Ratio	37.60%	151.90%	130.02%	-	45.22%	1.52%
Buyback Yield / Dilution	2.14%	1.82%	-21.93%	-8.34%	-6.51%	6.12%
Total Shareholder Return	2.70%	2.61%	-19.96%	-2.00%	-6.51%	6.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.